Michael D Buck

13PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursFood safety, traceability, certification and authenticityInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 20, 2026
Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.

|Jan 02, 2026
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity.

Kok Haw Jonathan Lim, Oliver Schulz, Irene Lobon

|Oct 30, 2025
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation.

Michael D Buck, Tomás Castro-Dopico, Oliver Schulz

|May 13, 2025
DNGR-1 regulates proliferation and migration of bone marrow dendritic cell progenitors.

Ana Cardoso, Michael D Buck, Bruno Frederico

|Apr 25, 2024
Vitamin D regulates microbiome-dependent cancer immunity.

Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam

|Mar 16, 2023
The dietary sweetener sucralose is a negative modulator of T cell-mediated responses.

Fabio Zani, Julianna Blagih, Tim Gruber

Pageof 3

Frequent Collaborators

10 joint publications

Caetano Reis e Sousa

8 joint publications

Neil Rogers

5 joint publications

Ana Cardoso

4 joint publications

Tomas Castro-Dopico